Abstract Background Cone contrast threshold testing (CCT) provides quantitative measurements of color and contrast function to reveal changes in vision quality that are not standard endpoints in clinical trials. We utilize CCT to measure visual function in patients with multiple sclerosis (MS). age-related macular degeneration (AMD). epiretinal membrane (ERM). https://www.ngetikin.com/great-pick-Borstlist-sjalvhaftande-Tesa-hot-grab/